A blood based 12-miRNA signature of Alzheimer disease patients
Petra Leidinger(Saarland University), Andreas Keller(Helmholtz Institute for Pharmaceutical Research Saarland), Jan Haas(Heidelberg University), Sabine Mueller(Fraunhofer Institute for Biomedical Engineering), Benjamin Meder(Heidelberg University), Klemens Ruprecht(Charité - Universitätsmedizin Berlin), Karen Frese(Heidelberg University), Cord Stähler(Siemens Healthineers (Germany)), Stephanie Deutscher(Saarland University), Eckart Meese(Saarland University), Friedemann Paul(Max Delbrück Center), Katja Schmitt(Saarland University), Tamás Bartfai(Translational Therapeutics (United States)), Christoph Läng(Friedrich-Alexander-Universität Erlangen-Nürnberg), Christina Backes(Saarland University)
Cited by 514
Related Papers
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
|Nature Methods|2017|1.3k
Distribution of miRNA expression across human tissues
|Nucleic Acids Research|2016|1k
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
|Journal of Neuroinflammation|2016|896
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740